A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/10 (2006.01) A61K 38/16 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 14/52 (2006.01)
Patent
CA 2408319
In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.
L'invention concerne des antagonistes du CXCR4 qui peuvent être utilisés pour traiter des cellules hématopoiétiques, telles que des cellules souches ou progénitrices, afin de promouvoir la vitesse de multiplication, d'auto-renouvellement, de prolifération ou d'expansion cellulaire. Les antagonistes du CXCR4 peuvent être utilisés de manière thérapeutique pour stimuler la multiplication/l'auto-renouvellement de cellules souches/progénitrices hématopoiétiques.
Arab Lakhdar
Cashman Johanne
Clark-Lewis Ian
Eaves Connie J.
Merzouk Ahmed
Chemokine Therapeutics Corporation
Gowling Lafleur Henderson Llp
The University Of British Columbia
LandOfFree
Cxcr4 antagonist treatment of hematopoietic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cxcr4 antagonist treatment of hematopoietic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr4 antagonist treatment of hematopoietic cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2025974